Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3408791rdf:typepubmed:Citationlld:pubmed
pubmed-article:3408791lifeskim:mentionsumls-concept:C1706515lld:lifeskim
pubmed-article:3408791lifeskim:mentionsumls-concept:C0079720lld:lifeskim
pubmed-article:3408791lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:3408791lifeskim:mentionsumls-concept:C1704640lld:lifeskim
pubmed-article:3408791lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:3408791lifeskim:mentionsumls-concept:C0596751lld:lifeskim
pubmed-article:3408791lifeskim:mentionsumls-concept:C0331858lld:lifeskim
pubmed-article:3408791pubmed:issue3lld:pubmed
pubmed-article:3408791pubmed:dateCreated1988-10-3lld:pubmed
pubmed-article:3408791pubmed:abstractTextNew polymeric solid-phase matrices for cell affinity chromatography were prepared and their advantageous characteristics compared with conventional matrices were highlighted. These new matrices are derivatives of poly(2-hydroxyethyl methacrylate) (PHEMA) containing a slight quantity of amino compounds as a co-monomer. They were applied to immunoaffinity selection between IgG+ and IgG- lymphocytes of the rat mesenteric lymph node. Simple physical adsorption was sufficient for anti-rat IgG antibodies to be immobilized on these matrices, allowing us to omit the laborious procedure of covalent-linking of antibodies on a matrix. As these matrices themselves showed extremely low non-specific adsorption of lymphocytes, a very dilute solution of antibody (0.02-0.08 mg/ml) was enough for column conditioning. This separation method gave IgG- lymphocytes of more than 90% purity and almost 95% yield within as short a time as 7 min. Further, IgG+ lymphocytes were obtained in good yield (80-90% of loaded number) by recovering the adsorbing cell fraction from the column by gentle pipetting of the matrix.lld:pubmed
pubmed-article:3408791pubmed:languageenglld:pubmed
pubmed-article:3408791pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3408791pubmed:citationSubsetIMlld:pubmed
pubmed-article:3408791pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3408791pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3408791pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3408791pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3408791pubmed:statusMEDLINElld:pubmed
pubmed-article:3408791pubmed:monthMaylld:pubmed
pubmed-article:3408791pubmed:issn0142-9612lld:pubmed
pubmed-article:3408791pubmed:authorpubmed-author:KataokaKKlld:pubmed
pubmed-article:3408791pubmed:authorpubmed-author:SakuraiYYlld:pubmed
pubmed-article:3408791pubmed:authorpubmed-author:TsurutaTTlld:pubmed
pubmed-article:3408791pubmed:authorpubmed-author:MaruyamaAAlld:pubmed
pubmed-article:3408791pubmed:authorpubmed-author:HanaiTTlld:pubmed
pubmed-article:3408791pubmed:issnTypePrintlld:pubmed
pubmed-article:3408791pubmed:volume9lld:pubmed
pubmed-article:3408791pubmed:ownerNLMlld:pubmed
pubmed-article:3408791pubmed:authorsCompleteYlld:pubmed
pubmed-article:3408791pubmed:pagination218-24lld:pubmed
pubmed-article:3408791pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:meshHeadingpubmed-meshheading:3408791-...lld:pubmed
pubmed-article:3408791pubmed:year1988lld:pubmed
pubmed-article:3408791pubmed:articleTitleImmunoaffinity chromatography of lymphocyte subpopulations using tert-amine derived matrices with adsorbed antibodies.lld:pubmed
pubmed-article:3408791pubmed:affiliationInstitute of Biomedical Engineering, Tokyo Women's Medical College, Japan.lld:pubmed
pubmed-article:3408791pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3408791pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed